View More View Less
  • 1 Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szeged, Semmelweis u. 6., 6720
  • | 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
  • | 3 Országos Vérellátó Szolgálat, Budapest
  • | 4 Debreceni Egyetem, Általános Orvostudományi Kar, Debrecen
Open access

Absztrakt:

Az életveszélyes periprocedurális vérzések növelik a perioperatív morbiditást és mortalitást, és koncentrált terhet rónak az egészségügyi betegellátó rendszer humán- és anyagi erőforrásaira. A nemzetközi transzfuziológiai gyakorlatban 2009 óta csökken a transzfúzióra került allogén készítmények mennyisége, ami a perioperatív vértakarékossági program és az életveszélyes perioperatív vérzések ellátására vonatkozó új innovációk térnyerésének köszönhető. A progresszív elemek adaptálása megkerülhetetlen feladatokat ró a magyarországi betegellátó rendszer gyógyítói és működtetői oldalára. A súlyosan vérző betegek ellátásának legfontosabb új elemeit a stabil koagulációsfaktor-koncentrátumok első vonalbeli használata, a betegágy melletti viszkoelasztikus véralvadási tesztek és az irányelvek együttes alkalmazása képezi. Napjaink és a közeljövő másik, a betegellátás teljes vertikumát átható problémáját a fenyegető vérkészítmény-ellátási nehézségek jelentik. Az életveszélyes perioperatív vérzések ellátásához kapcsolódó diagnosztikus és terápiás modalitások részben új erőforrásokat igényelnek, de az allogén készítményekre és a faktorkoncentrátumra fordítható pénzügyi keretek intézeti/intézményi szintű, országosan szervezett átjárhatóvá tételével megteremthetnénk a faktorkoncentrátumok első vonalbeli használatának anyagi lehetőségét, és jelentős vérmegtakarítást érhetnénk el. Orv Hetil. 2019; 160(6): 203–213.

  • 1

    Vuylsteke A, Pagel C, Gerrard C, et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg. 2011; 39: 924–930.

  • 2

    Thiele RH, Raphael J. A 2014 update on coagulation management for cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth. 2014; 18: 177–189.

  • 3

    Karkouti K, Callum J, Wijeysundera DN, et al. Point-of-care hemostatic testing in cardiac surgery. A stepped-wedge clustered randomized controlled trial. Circulation 2016; 134: 1152–1162.

  • 4

    Curry N, Hopewell S, Dorée C, et al. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care 2011; 15: R92.

  • 5

    Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100.

  • 6

    Knapp J, Hofer S, Lier H. Anesthesiological approach to postpartum hemorrhage. Anaesthesist 2016; 65: 225–240.

  • 7

    Joseph KS, Rouleau J, Kramer MS, et al. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007; 114: 751–759.

  • 8

    Besser MW, Ortmann E, Klein AA. Haemostatic management of cardiac surgical haemorrhage. Anaesthesia 2015; 70(Suppl 1): 87–95. e29–e31.

  • 9

    Görlinger K, Fries D, Dirkmann D, et al. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother. 2012; 39: 104–113.

  • 10

    Christensen MC, Dziewior F, Kempel A, et al. Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 2012; 26: 46–51.

  • 11

    Christensen MC, Krapf S, Kempel A, et al. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg. 2009; 138: 687–693.

  • 12

    Campbell HE, Stokes EA, Bargo DN, et al. Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England. Crit Care 2015; 19: 276.

  • 13

    Shem Tov L, Matot I. Frailty and anesthesia. Curr Opin Anaesthesiol. 2017; 30: 409–417.

  • 14

    Kálmán S, Pákáski M, Kálmán J. Frailty syndrome: an old new friend. [Esendőségszindróma: egy régi új ismerős.] Orv Hetil. 2014; 155: 1935–1951. [Hungarian]

  • 15

    Babik B, Peták F, Agócs S, et al. Diabetes mellitus: endothelial dysfunction and changes in hemostasis. [Diabetes mellitus: endotheldiszfunkció és haemostasiselváltozások.] Orv Hetil. 2018; 159: 1335–1345. [Hungarian]

  • 16

    Ellingson KD, Sapiano MR, Haass KA, et al. Continued decline in blood collection and transfusion in the United States – 2015. Transfusion 2017; 57(Suppl 2): 1588–1598.

  • 17

    Whitaker B, Rajbhandary S, Kleinman S, et al. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey. Transfusion 2016; 56: 2173–2183.

  • 18

    Farmer SL, Towler SC, Leahy MF, et al. Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). Best Pract Res Clin Anaesthesiol. 2013; 27: 43–58.

  • 19

    Arora RC, Brown CH 4th, Sanjanwala RM, et al. “NEW” prehabilitation: a 3-way approach to improve postoperative survival and health-related quality of life in cardiac surgery patients. Can J Cardiol. 2018; 34: 839–849.

  • 20

    Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008; 359: 938–949.

  • 21

    Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995; 81: 360–365.

  • 22

    Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol. Am J Clin Pathol. 2011; 136: 364–370.

  • 23

    Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011; 39: 2652–2658.

  • 24

    Schöchl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265.

  • 25

    Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 2008; 12: R105.

  • 26

    Fenger-Eriksen C, Ingerslev J, Sørensen B. Fibrinogen concentrate – a potential universal hemostatic agent. Expert Opin Biol Ther. 2009; 9: 1325–1333.

  • 27

    Rahe-Meyer N, Sørensen B. Fibrinogen concentrate for management of bleeding. J Thromb Haemost. 2011; 9: 1–5.

  • 28

    Velik-Salchner C, Haas T, Innerhofer P, et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost. 2007; 5: 1019–1025.

  • 29

    Babik B, Fazakas J. (eds). Management of severe perioperative bleeding. [Az életveszélyes perioperatív vérzések ellátása. A Magyar Aneszteziológiai és Intenzív Terápiás Társaság szakmai irányelve, 2013.] [Hungarian]

  • 30

    Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008; 6: 622–631.

  • 31

    Levy JH, Tanaka KA, Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008; 109: 918–926.

  • 32

    Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol. 2008; 25: 784–789.

  • 33

    Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth. 2008; 101: 769–773.

  • 34

    Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79–S85; discussion S85.

  • 35

    Schöchl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.

  • 36

    Rahe-Meyer N, Hanke A, Schmidt DS, et al. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg. 2013; 145: S178–S185.

  • 37

    Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531–547.

  • 38

    Solomon C, Pichlmaier U, Schoechl H, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth. 2010; 104: 555–562.

  • 39

    Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40–50.

  • 40

    Wikkelsø AJ, Edwards HM, Afshari A, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015; 114: 623–633.

  • 41

    Ranucci M, Baryshnikova E. Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). Br J Anaesth. 2016; 116: 618–623.

  • 42

    Wikkelsø A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev. 2013; 8: CD008864.

  • 43

    Aubron C, Reade MC, Fraser JF, et al. Efficacy and safety of fibrinogen concentrate in trauma patients – a systematic review. J Crit Care 2014; 29: 471.e11–471.e17.

  • 44

    Lunde J, Stensballe J, Wikkelsø A, et al. Fibrinogen concentrate for bleeding – a systematic review. Acta Anaesthesiol Scand. 2014; 58: 1061–1074.

  • 45

    Solomon C, Gröner A, Ye J, et al. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data. Thromb Haemost. 2015; 113: 759–771.

  • 46

    Hellstern P. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency. Thromb Res. 1999; 95(Suppl 1): S7–S12.

  • 47

    Vigué B, Ract C, Tremey B, et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med. 2007; 33: 721–725.

  • 48

    Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007; 21: 37–48.

  • 49

    Bolliger D, Tanaka KA. Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost. 2017; 43: 386–396.

  • 50

    Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005; 27: 81–90.

  • 51

    Grottke O, Henzler D, Spahn DR, et al. Coagulopathy in multiple trauma: new aspects of therapy. Anaesthesist 2007; 56: 95–106; quiz 107–108.

  • 52

    Schöchl H, Maegele M, Solomon C, et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012; 20: 15.

  • 53

    Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol. 2007; 73: 401–415.

  • 54

    Briggs C, Guthrie D, Hyde K, et al. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008; 142: 904–915.

  • 55

    Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008; 100: 792–797.

  • 56

    Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005; 95: 130–139.

  • 57

    Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Crit Care 2007; 11: R17.

  • 58

    Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.

  • 59

    Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76.

  • 60

    Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008; 248: 447–458.

  • 61

    Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma 2008; 65: 261–270; discussion 270–271.

  • 62

    Teixeira PG, Inaba K, Shulman I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009; 66: 693–697.

  • 63

    Stensballe J, Henriksen HH, Johansson PI. Early haemorrhage control and management of trauma-induced coagulopathy: the importance of goal-directed therapy. Curr Opin Crit Care 2017; 23: 503–510.

  • 64

    Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol. 2017; 34: 332–395.

  • 65

    Babik B. Hemostasis in pregnancy: a natural model of hemostasis. Resuscitation in patients with massive perioperative blood loss. [A véralvadási rendszer adaptációja terhességben: a hemosztázisreszuszcitáció természetes modellje masszív vérzésben. Aneszteziol Int Ter. 2017; 47: 9–23. [Hungarian]

  • 66

    Baryshnikova E, Ranucci M. Point-of-care haemostasis and coagulation monitoring in cardiac surgery at IRCCS Policlinico San Donato. Eur Heart J Suppl. 2016; 18(Suppl E): E42–E48.

  • 67

    Brohi KE, Eaglestone S. Traumatic coagulopathy and massive transfusion: improving outcomes and saving blood. Programme Grants for Applied Research 5: 19. Southampton (UK), NIHR Journals Library, November 2017.

  • 68

    Naik BI, Pajewski TN, Bogdonoff DI, et al. Rotational thromboelastometry-guided blood product management in major spine surgery. J Neurosurg Spine 2015; 23: 239–249.

  • 69

    Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012; 109: 851–863.

  • 70

    Fahrendorff M, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products – A systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2017; 25: 39.

  • 71

    Wikkelsø A, Wetterslev J, Møller AM, et al. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2017; 72: 519–531.

  • 72

    Tang M, Fenger-Eriksen C, Wierup P, et al. Rational and timely haemostatic interventions following cardiac surgery – coagulation factor concentrates or blood bank products. Thromb Res. 2017; 154: 73–79.

  • 73

    Chee YE, Liu SE, Irwin MG. Management of bleeding in vascular surgery. Br J Anaesth. 2016; 117(Suppl 2): ii85–ii94.

  • 74

    Neb H, Zacharowski K, Meybohm P. Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol. 2017; 30: 294–299.

  • 75

    Rahe-Meyer N, Levy JH, Mazer CD, et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth. 2016; 117: 41–51.

  • 76

    Samama CM, Ickx B, Ozier Y, et al. The place of fibrinogen concentrates in the management of perioperative bleeding: a position paper from the Francophone Working Group on Perioperative Haemostasis (GIHP). Anaesth Crit Care Pain Med. 2018; 37: 355–365.

  • 77

    Williamson LM, Devine DV. Challenges in the management of the blood supply. Lancet 2013; 381: 1866–1875.

  • 78

    Udvardy M. A new era of transfusion-transmitted pathogens, infections. Renewed need for updating standards for clinicans along with blood banking. [Új korszak és új szempontok a transzfúziós kórokozó-átvitel kockázatában, különös tekintettel a rendszeres plazmaeredetű készítményre szoruló haemophiliás betegekre.] Orv Hetil. 2018; 159: 1495–1500. [Hungarian]

  • 79

    Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179–1191.

  • 80

    Hanke AA, Herold U, Dirkmann D, et al. Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type A aortic dissection: a pilot study. Transfus Med Hemother. 2012; 39: 121–128.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 8 12
Feb 2021 0 12 21
Mar 2021 0 21 7
Apr 2021 0 15 13
May 2021 0 6 9
Jun 2021 0 7 7
Jul 2021 0 0 0